Search
for
Sort by
Research 91–120 of 107
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Evaluation of Efficacy of Low-Level Laser Therapy
- Thirty Years of Autologous Platelet Concentrates: From Platelet‐Rich Plasma to Platelet‐Rich Fibrin
- The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
- Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women
- Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Total prostate volume as risk factor for semen pathologies in ageing male
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- Finasteride
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study
- Thrombocytosis Associated with Low-Molecular-Weight Heparin